Every state, kept current
The Rates plan
$29/mo7-day free trialThis page shows one representative rate per state for Q5115. Full schedules include every locality, modifier, and age-band variant.
- Every code on all 51 published schedules
- Full-schedule CSV export and state network lists
- Email alerts when a state changes its rates
$29/mo after the trial. Cancel anytime.
Publishing states
31
Median % of Medicare
--
Rate range
$26.04 - $96.40
Q5115 rates in every publishing state
| State | Medicaid rate | % of Medicare | Prior auth | Vintage |
|---|---|---|---|---|
| Alabama | $29.38 | -- | -- | 2026 |
| Arkansas | $96.40 | -- | -- | 2026 |
| Arizona | $30.24 | -- | -- | 2026 |
| California | $31.28 | -- | -- | 2026 |
| Connecticut | $35.89 | -- | -- | 2024 |
| District of Columbia | $30.15 | -- | Required | 2026 |
| Iowa | $85.64 | -- | -- | 2024 |
| Idaho | $26.04 | -- | Not required | 2026 |
| Illinois | $30.43 | -- | -- | 2026 |
| Indiana | $88.78 | -- | -- | 2020 |
| Kansas | $34.56 | -- | -- | 2026 |
| Kentucky | $30.15 | -- | -- | 2026 |
| Maine | $34.56 | -- | -- | 2026 |
| Michigan | $34.56 | -- | -- | 2026 |
| Minnesota | $33.92 | -- | Required | 2026 |
| Mississippi | $31.28 | -- | -- | 2026 |
| Montana | $30.15 | -- | -- | 2026 |
| North Carolina | $34.56 | -- | -- | 2026 |
| Nebraska | $34.56 | -- | -- | 2026 |
| New Hampshire | $84.56 | -- | Not required | 2026 |
| New Jersey | $83.81 | -- | Not required | 2026 |
| New Mexico | $31.83 | -- | -- | 2025 |
| Oklahoma | $34.56 | -- | -- | 2026 |
| South Carolina | $33.18 | -- | -- | 2026 |
| Texas | $31.18* | -- | -- | 2026 |
| Utah | $34.56* | -- | Not required | 2026 |
| Virginia | $33.92 | -- | -- | 2026 |
| Vermont | $27.91 | -- | -- | 2026 |
| Washington | $34.56 | -- | -- | 2026 |
| Wisconsin | $34.56 | -- | -- | 2026 |
| Wyoming | $53.02 | -- | -- | 2022 |
Published Medicaid fee-for-service schedule amounts, not a coverage or eligibility guarantee. Managed-care plan rates can differ. Where no prior-authorization flag is shown, the state does not publish one. Rows marked * are representative published variants or methodology-derived rates. "--" in the prior-auth column means the state publishes no PA flag.
Related state-specific services codes
- C1716 - Brachytherapy source, non-stranded, gold-198, per source
- C1717 - Brachytherapy source, non-stranded, high dose rate iridium-192, per source
- C1719 - Brachytherapy source, non-stranded, non-high dose rate iridium-192, per source
- C2616 - Brachytherapy source, non-stranded, yttrium-90, per source
- C2634 - Brachytherapy source, non-stranded, high activity, iodine-125, greater than 1.01 mci (nist), per source
- C2635 - Brachytherapy source, non-stranded, high activity, palladium-103, greater than 2.2 mci (nist), per source
- C2636 - Brachytherapy linear source, non-stranded, palladium-103, per 1 mm
- C2638 - Brachytherapy source, stranded, iodine-125, per source
All 56 codes from Q5098 to Q5167 or every state-specific services code by number.
Frequently asked questions
How much does Medicaid pay for Q5115?
31 state Medicaid programs publish a fee-for-service rate for Q5115 (injection, rituximab-abbs, biosimilar, (truxima), 10 mg), ranging from $26.04 in Idaho to $96.40 in Arkansas. The full table on this page lists every publishing state's current rate.
Which state pays the most for Q5115?
Arkansas publishes the highest Medicaid rate for Q5115 at $96.40. Idaho publishes the lowest at $26.04.
Does Q5115 require prior authorization under Medicaid?
2 of the 31 publishing states flag Q5115 as requiring prior authorization (always or conditionally) on their fee schedules. States without a flag publish no PA indicator for this code - that means "not published", not "no PA required".